Article
Characterization of a gyrB mutation responsible for low-level nalidixic acid resistance in Neisseria gonorrhoeae.
Antimicrobial agents and chemotherapy - 1 Apr 1991
Stein D C, Danaher R J, Cook T M
Abstract excerpt
Nalidixic acid-resistant derivatives of Neisseria gonorrhoeae WR302 were identified and categorized into two classes on the basis of their susceptibilities to this antimicrobial agent. The MIC of nalidixic acid for the derivative strain MUG116 was fourfold greater than that for its isogenic parental strain WR302 (2 versus 0.5 micrograms/ml, respectively). MUG324 was significantly more resistant to nalidixic acid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
